Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis
Asian Cardiovascular and Thoracic Annals2021Vol. 29(8), pp. 717–728
Citations Over TimeTop 13% of 2021 papers
Fajar Perdhana, Nabila Ananda Kloping, Andro Pramana Witarto, David Nugraha, Niwanda Yogiswara, Kevin Luke, Yudhistira Pradnyan Kloping, Nancy Margarita Rehatta
Abstract
Adjunct administration of methylene blue for vasoplegic syndrome patients significantly reduces renal failure, multiple organ failure, and mortality.
Related Papers
- A Meta Analysis of Jiang Ya Bao in Treatment of essential hypertension(2015)
- → Auriculoterapia para el control del dolor postoperatorio: una revisión sistemática de ensayos clínicos aleatorizados(2009)
- → A note on the evaluation of BoNTA trial quality(2011)
- → CHEWING GUM AND CARIES: Authors’ response(2009)
- Quality Evaluation of Literature of Integrated Chinese-western Therapy for Cough Variant Asthma(2012)